Skip to main content
Erschienen in: Neurocritical Care 1/2008

01.08.2008 | Original Article

The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring

verfasst von: Santiago J. Munoz, K. Rajender Reddy, William Lee, The Acute Liver Failure Study Group

Erschienen in: Neurocritical Care | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The development of coagulopathy in acute liver failure (ALF) is universal. The severity of the coagulopathy is often assessed by determination of the prothrombin time and International Normalized Ratio (INR).

Discussion

In more than 1,000 ALF cases, the severity of the coagulopathy was moderate in 81% (INR 1.5–5.0), severe in 14% (INR 5.0–10.0), and very severe in 5% (INR > 10.0). Certain etiologies were associated with more severe coagulopathy, whereas ALF caused by fatty liver of pregnancy had the least severe coagulopathy.

Methods

Management consisted of transfusions of FFP in 92%. Overall, FFP administered during the first week of admission amounted to 13.7 ± 15 units.

Results

Patients who received an ICP monitor had significantly more FFP transfused than those managed without ICP monitor (22.7 ± 2.4 vs. 12.3 ± 0.8 units FFP; P < 0.001). Only a minority of patients developed gastrointestinal bleeding or had an intracranial pressure monitor installed.

Conclusion

Further research is necessary to explore the reasons clinicians transfuse ALF patients with large amounts of FFP in the absence of active bleeding or invasive procedures.
Literatur
1.
Zurück zum Zitat Schiodt F, Atillasoy E, Shakil O, Schiff E, Caldwell C, Kowdley K, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. 1999;5:29–34.CrossRef Schiodt F, Atillasoy E, Shakil O, Schiff E, Caldwell C, Kowdley K, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl. 1999;5:29–34.CrossRef
2.
Zurück zum Zitat Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med. 2002;137:947–54.PubMed Ostapowicz G, Fontana R, Schiodt F, Larson A, Davern T, Han S, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Int Med. 2002;137:947–54.PubMed
3.
Zurück zum Zitat Clark R, Rake MO, Flute PT, Williams R. Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroent (Suppl). 1973;19:63–70. Clark R, Rake MO, Flute PT, Williams R. Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroent (Suppl). 1973;19:63–70.
4.
Zurück zum Zitat Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Sem Liver Dis. 1996;16:403–14. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Sem Liver Dis. 1996;16:403–14.
5.
Zurück zum Zitat Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–78.PubMedCrossRef Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–78.PubMedCrossRef
6.
Zurück zum Zitat Lisman T, Leebeek F. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250–8.PubMedCrossRef Lisman T, Leebeek F. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250–8.PubMedCrossRef
7.
Zurück zum Zitat O’Grady JG, Langley PG, Sisola L, Aladort L, Williams R. Coagulopathy of fulminant hepatic failure. Sem Liver Dis. 1986;6:159–63. O’Grady JG, Langley PG, Sisola L, Aladort L, Williams R. Coagulopathy of fulminant hepatic failure. Sem Liver Dis. 1986;6:159–63.
8.
Zurück zum Zitat Lisman T, Leebeek FWG, de Groot P. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280–7.PubMedCrossRef Lisman T, Leebeek FWG, de Groot P. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280–7.PubMedCrossRef
9.
Zurück zum Zitat Caldwell SH, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, et al. Coagulation disorders and hemostasis in liver disease: physiopathology and critical assessment of current management. Hepatology. 2006;44:1039–46.PubMedCrossRef Caldwell SH, Hoffman M, Lisman T, Macik B, Northup P, Reddy K, et al. Coagulation disorders and hemostasis in liver disease: physiopathology and critical assessment of current management. Hepatology. 2006;44:1039–46.PubMedCrossRef
10.
Zurück zum Zitat Stravitz RT, Kramer AH, Davern T, Shaikh O, Caldwell S, Mehta R, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.PubMed Stravitz RT, Kramer AH, Davern T, Shaikh O, Caldwell S, Mehta R, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.PubMed
11.
Zurück zum Zitat Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617–20.PubMedCrossRef Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975;16:617–20.PubMedCrossRef
12.
Zurück zum Zitat Rueff B, Benhamou JP. Acute hepatic necrosis and fulminant hepatic failure. Gut. 1973;14:805–14.PubMedCrossRef Rueff B, Benhamou JP. Acute hepatic necrosis and fulminant hepatic failure. Gut. 1973;14:805–14.PubMedCrossRef
13.
Zurück zum Zitat Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–98.PubMed
14.
Zurück zum Zitat Munoz S. Prothrombin time in fulminant hepatic failure. Gastroenterology. 1991;100:1480–9.PubMed Munoz S. Prothrombin time in fulminant hepatic failure. Gastroenterology. 1991;100:1480–9.PubMed
15.
Zurück zum Zitat Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005: 41:553–8.PubMedCrossRef Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005: 41:553–8.PubMedCrossRef
16.
Zurück zum Zitat Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemostasis. 2006;4:717–20.CrossRef Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemostasis. 2006;4:717–20.CrossRef
17.
Zurück zum Zitat Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392–4.PubMedCrossRef Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996;24:1392–4.PubMedCrossRef
18.
Zurück zum Zitat MacDougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617–9.PubMedCrossRef MacDougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617–9.PubMedCrossRef
19.
Zurück zum Zitat Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157–8.PubMedCrossRef Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet. 1993;341:157–8.PubMedCrossRef
20.
Zurück zum Zitat Vaquero J, Fontana RJ, Larson A, Bass N, Davern T, Shakil O, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581–9.PubMedCrossRef Vaquero J, Fontana RJ, Larson A, Bass N, Davern T, Shakil O, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005;11:1581–9.PubMedCrossRef
21.
Zurück zum Zitat Donaldson BW, Gopinath R, Wanless I, Phillips M, Cameron R, Roberts E, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–6.PubMed Donaldson BW, Gopinath R, Wanless I, Phillips M, Cameron R, Roberts E, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–6.PubMed
22.
Zurück zum Zitat Mor E, Jennings L, Gonwa TA, Holman M, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gyn Obst. 1993;176:219–27.PubMed Mor E, Jennings L, Gonwa TA, Holman M, Gibbs J, Solomon H, et al. The impact of operative bleeding on outcome in transplantation of the liver. Surg Gyn Obst. 1993;176:219–27.PubMed
23.
Zurück zum Zitat O’Grady JG, Alexander GJ, Thick M, Potter D, Calne R, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988;68:817–24.PubMed O’Grady JG, Alexander GJ, Thick M, Potter D, Calne R, Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988;68:817–24.PubMed
24.
Zurück zum Zitat Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050–5.PubMedCrossRef Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050–5.PubMedCrossRef
25.
Zurück zum Zitat Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatolog Wily. 1995;21:1018–24.PubMedCrossRef Devlin J, Wendon J, Heaton N, Tan K, Williams R. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatolog Wily. 1995;21:1018–24.PubMedCrossRef
26.
Zurück zum Zitat Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid S, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666–75.PubMedCrossRef Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid S, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666–75.PubMedCrossRef
27.
Zurück zum Zitat Muñoz S. Difficult management problems in fulminant hepatic failure. Sem Liver Dis. 1993;13:395–413. Muñoz S. Difficult management problems in fulminant hepatic failure. Sem Liver Dis. 1993;13:395–413.
28.
Zurück zum Zitat Munoz S, Stravitz R, Gabriel D. Coagulopathy of acute liver failure. Clin Liver Dis. 2008; in press. Munoz S, Stravitz R, Gabriel D. Coagulopathy of acute liver failure. Clin Liver Dis. 2008; in press.
29.
Zurück zum Zitat Shami V, Caldwell S, Hespenheide E. Recombinant activated factor VII for the coagulopathy of fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138–43.CrossRef Shami V, Caldwell S, Hespenheide E. Recombinant activated factor VII for the coagulopathy of fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9:138–43.CrossRef
30.
Zurück zum Zitat Quan D, Bass N, Hirose R. The effect of recombinant factor VIIa and fresh frozen plasma on the INR in patients with acute and chronic liver failure. Hepatology. 2003;38(4):550A.CrossRef Quan D, Bass N, Hirose R. The effect of recombinant factor VIIa and fresh frozen plasma on the INR in patients with acute and chronic liver failure. Hepatology. 2003;38(4):550A.CrossRef
31.
Zurück zum Zitat Porte R, Caldwell S. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11:872–4.CrossRef Porte R, Caldwell S. The role of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11:872–4.CrossRef
Metadaten
Titel
The Coagulopathy of Acute Liver Failure and Implications for Intracranial Pressure Monitoring
verfasst von
Santiago J. Munoz
K. Rajender Reddy
William Lee
The Acute Liver Failure Study Group
Publikationsdatum
01.08.2008
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 1/2008
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-008-9087-6

Weitere Artikel der Ausgabe 1/2008

Neurocritical Care 1/2008 Zur Ausgabe

Tell Me Something I Need To Know

How I Treat Status Epilepticus in the Neuro-ICU

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.